1. Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer
   Yarini Arrebola Sánchez et al, 2023, Physical Sciences Reviews CrossRef
2. Diversity of amyloid beta peptide actions
   Sona Mardanyan et al, 2024, Reviews in the Neurosciences CrossRef
3. Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
   Weifen Zhang et al, 2018, Frontiers in Oncology CrossRef
4. Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
   Petr Busek et al, 2022, Cancers CrossRef
5. Fibroblast Activation Protein Expression in Sarcomas
   Jacquelyn N. Crane et al, 2023, Sarcoma CrossRef
6. FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?
   Katharina Dendl et al, 2021, Cancers CrossRef
7. The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS – a critical overview
   Hans-Gert Bernstein et al, 2023, Reviews in the Neurosciences CrossRef
8. The Effectiveness of Antidiabetic Drugs in Treating Dementia: A Peek into Pharmacological and Pharmacokinetic Properties
   Jiro Ogura et al, 2022, International Journal of Molecular Sciences CrossRef
9. P53 together with ferroptosis: a promising strategy leaving cancer cells without escape
   Jianhao Zhan et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
10. Activatable Near-Infrared Fluorescent Probe for Dipeptidyl Peptidase IV and Its Bioimaging Applications in Living Cells and Animals
    Tao Liu et al, 2018, Analytical Chemistry CrossRef
11. Activity-Based Fluorescence Diagnostics for Cancer
    Kyohhei Fujita et al, 2024, Chemical Reviews CrossRef
12. Spray Fluorescent Probes for Fluorescence-Guided Neurosurgery
    Yosuke Kitagawa et al, 2019, Frontiers in Oncology CrossRef
13. New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
    Chenkai Cui et al, 2022, Frontiers in Pharmacology CrossRef
14. The role of fibroblast activation protein in health and malignancy
    Allison A. Fitzgerald et al, 2020, Cancer and Metastasis Reviews CrossRef
15. Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases
    Xiaopeng Hu et al, 2022, Molecules CrossRef
16. DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness
    Peir-In Liang et al, 2017, Oncotarget CrossRef